|

Lysogenic HSV virus. Clinical Trials

2 actively recruiting trials

Also known as: Biological agent

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • West China Hospital2

Indications

  • Lysogenic HSV Virus2
  • Targeted Therapy2
  • HNSCC2
  • Immunotherapy2
  • Neoadjuvant Therapy2

Other2 trials

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
Phase 1
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.